financetom
Business
financetom
/
Business
/
Gen Digital Fiscal Q3 Adjusted EPS, Revenue Rise; 2025 Guidance Updates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gen Digital Fiscal Q3 Adjusted EPS, Revenue Rise; 2025 Guidance Updates
Jan 30, 2025 2:22 PM

05:02 PM EST, 01/30/2025 (MT Newswires) -- Gen Digital ( GEN ) reported fiscal Q3 non-GAAP net income late Thursday of $0.56 per diluted share, up from $0.49 a year ago.

Analysts polled by FactSet expected $0.55.

Net revenue in the three months ended Dec. 27 was $986 million, compared with $948 million a year ago. Analysts expected $985.1 million.

For Q4, the cybersecurity company non-GAAP EPS of $0.57 to $0.59 on $990 million to $1.01 billion in revenue. Analysts are looking for $0.58 and $995.6 million, respectively.

For fiscal 2025, Gen Digital ( GEN ) is projecting non-GAAP EPS of $2.20 to $2.22 on between $3.92 billion to $3.93 billion in revenue compared with its prior guidance expecting EPS of $2.18 to $2.23 on $3.91 billion to $3.93 billion in revenue.

Analysts are looking for $2.21 and $3.92 billion, respectively.

The company also declared a quarterly dividend of $0.125 a share, unchanged from the prior quarter and payable March 12 to investors of record on Feb. 17.

Gen Digital ( GEN ) shares were falling nearly 1% in extended session.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug
Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug
Mar 26, 2025
NEW YORK (Reuters) -The biotechnology company Cassava Sciences ( SAVA ) failed on Wednesday to end a malicious prosecution lawsuit by doctors and short-sellers who expressed doubts about its experimental, soon-to-be-discontinued Alzheimer's drug simufilam. U.S. District Judge Jennifer Rochon in Manhattan said Adrian Heilbut, Jesse Brodkin, Enea Milioris, David Bredt and Geoffrey Pitt could try to prove that Cassava knew...
Trump: Going to go with tariffs on cars
Trump: Going to go with tariffs on cars
Mar 26, 2025
WASHINGTON, March 26 (Reuters) - President Donald Trump said on Wednesday he plans to announce tariffs on imported autos during an event later in the day. We're going to go with the tariffs on cars, Trump said ahead of the formal announcement in the Oval Office later on Wednesday. ...
Immunome Insider Bought Shares Worth $999,459, According to a Recent SEC Filing
Immunome Insider Bought Shares Worth $999,459, According to a Recent SEC Filing
Mar 26, 2025
04:11 PM EDT, 03/26/2025 (MT Newswires) -- Clay B Siegall, Director, President and CEO, on March 26, 2025, executed a purchase for 137,100 shares in Immunome ( IMNM ) for $999,459. Following the Form 4 filing with the SEC, Siegall has control over a total of 806,736 common shares of the company, with 806,736 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1472012/000141588925009017/xslF345X05/form4-03262025_080357.xml...
Market Chatter: Discord Working With JPMorgan, Goldman on IPO in 2025
Market Chatter: Discord Working With JPMorgan, Goldman on IPO in 2025
Mar 26, 2025
03:54 PM EDT, 03/26/2025 (MT Newswires) -- Discord, a social communications platform, is working with JPMorgan Chase (JPM) and Goldman Sachs (GS) on a planned IPO for listing as early as this year, Bloomberg reported Wednesday, citing sources. Discord and the banking institutions declined to comment to Bloomberg. The sources told the news outlet that Discord's plans for IPO, including...
Copyright 2023-2026 - www.financetom.com All Rights Reserved